tellmeGen
tellmeGen
Valid for: Starter, Advanced, and ULTRA (WGS 30x)
Last updated: September 9, 2025
Responsible for the service and processing: GENELINK, S.L. (“tellmeGen”).
Provision of service: EEE, mainly from Spain, with laboratories in Denmark and/or Spain.
General contact: info@tellmegen.com — Privacy and rights: lopd@tellmegen.com — DPO: dpo@tellmegen.com
Supervisory authority: AEPD or your national authority.
Before hiring, you must read, understand, and expressly accept this Consent. By checking the box, you declare that:
- knows the service process and its benefits and limitations;
- understands that the reports have an informative and educational purpose and are not a medical diagnosis;
- authorizes the analysis of their saliva sample and the treatment of their genetic data on the following terms;
- declares to be over 18 years of age or to act as the legal representative of the minor or incapacitated person, providing the necessary documentation.
Legal basis: performance of the contract + explicit consent for genetic data.
- Starter: ancestry, traits, and well-being.
- Advanced: the above and also multifactorial predispositions, carrier status and pharmacogenetics (microarrays).
- ULTRA (30x): whole genome sequencing that allows studying a broader spectrum of variants.
This service is not intended to prevent, diagnose, treat, or cure diseases. Clinical decisions require confirmation by healthcare professionals in an accredited setting.
You collect the saliva sample following the kit. We analyze it in European laboratories and process the data with our software.
- Starter/Advanced: microarrays (and, where applicable, statistical imputation).
- ULTRA: WGS 30x. The detection of certain variants or regions may be limited by the technology.
Self-knowledge, informed conversation with healthcare professionals, possible pharmacogenetic guidance (always with your doctor), ancestry and traits, and potential utility for biological relatives.
- Genetics does not determine the development of a disease on its own.
- Unexpected information (e.g., unforeseen relationships or findings) and variants of uncertain significance may appear.
- The results may have family implications.
- Although we apply strict security measures, no system is completely immune to risks.
- Receiving genetic information can generate anxiety or doubts. We recommend discussing the results with your doctor and a genetic counseling professional.
Do not use the reports for employment, insurance, immigration, legal paternity, forensic purposes, or for any discriminatory or illegal purpose.
- Incidental findings (ULTRA): you may choose whether or not to receive clinically actionable findings per a recognized list (e.g., current ACMG SF). You may change your preference before results are issued.
- Research: if authorized, we may use pseudonymized or anonymized data in our own or collaborative projects.
- Professional Access: you can share with healthcare professionals through the platform and revoke access whenever you want.
- Connection/community features (e.g., DNA Connect): require voluntary opt-in.
The sample is used exclusively for the contracted purpose and is destroyed approx. in 60–120 days from the emission of results and, in any case, before 6 months, unless a different legal obligation exists.
If the sample is invalid for reasons not attributable to you, we may offer a re-run in accordance with the current policy visible on the platform.
ULTRA: data storage and functions may require tellmeGen+ from month 13 onwards. There is a 1 year grace period after expiry; after that time without reactivating the subscription, WGS data will be securely deleted (including backups ≤90 days).
You may access, rectify, erase, restrict or object, request portability and withdraw your consent at any time by writing to lopd@tellmegen.com. Withdrawal of main consent prevents continued provision of the service and entails the deletion of data, except for legal obligations of conservation. If you withdraw an optional permission, only that processing will cease.
Hiring requires 18 years or older. For minors or incapacitated individuals, consent is given by the legal representative, who must prove it. Do not send samples or third-party data without sufficient legitimacy.
10.1. Pre-test genetic counseling (pre-employment information).
Before contracting, you acknowledge and agree that this Consent, together with the pre-contractual information available on the tellmeGen website and platform (e.g., description of Starter/Advanced/ULTRA services, benefits and limitations, risks, FAQs and informative materials), constitutes the pre-test genetic counseling of the direct-to-consumer (DTC) service. You declare to have read and understood said information, to have been able to formulate reasonable doubts before contracting and that your decision to acquire the service is free and voluntary, without clinical prescription or indication. In the case of minors or incapacitated persons, the legal representative states to have provided and explained this information to the represented person in a manner appropriate to their age and understanding.
10.2. Post-test genetic counseling (support after results delivery).
After the emission of results, tellmeGen makes available to you on the platform support content (tutorials, guides, glossaries, explanations of each section of the report, and educational resources) that constitute post-test genetic counseling. Additionally, you can schedule consultations with tellmeGen geneticists through the channels enabled on the platform to resolve doubts about your results. These consultations and materials are informative and educational in nature; they do not constitute medical acts nor do they replace diagnosis, follow-up, or treatment by healthcare professionals. Any clinical decision must be made with a healthcare professional and, if applicable, confirmed in an accredited environment.
10.3. Scope and limitations.
[ ] I accept the Informed Consent and authorize the processing of my genetic data as described.
[ ] ULTRA: I wish to receive clinically actionable secondary/incidental findings.
[ ] Research with pseudonymized/anonymized data.
[ ] Professional Access: I authorize sharing my results with [professional] and understand that I can revoke access.
[ ] DNA Connect: I activate the functionality at my will.